| 1 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D09214 
                
                    D09214
                
             | 
                
                    Ustekinumab
                
             | 17件:  37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 | 
| 2 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D10400 
                
                    D10400
                
             | 
                
                    Tildrakizumab
                
             | 2件:  162 162, 271 | 
| 3 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D10438 
                
                    D10438
                
             | 
                
                    Guselkumab
                
             | 5件:  37 37, 41, 51, 96, 97 | 
| 4 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D10912 
                
                    D10912
                
             | 
                
                    Brazikumab
                
             | 2件:  96 96, 97 | 
| 5 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D11052 
                
                    D11052
                
             | 
                
                    Risankizumab
                
             | 4件:  37 37, 96, 97, 271 | 
| 6 | 
                
                    IL23A
                
             | 9件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | D11123 
                
                    D11123
                
             | 
                
                    Mirikizumab
                
             | 3件:  37 37, 96, 97 |